Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines-Reference-Cited by-同舟云学术

Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines

Published:2012-06 Issue:12 Volume:75 Page:3747-3759
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Alhamdani Mohamed Saiel Saeed,Youns Mahmoud,Buchholz Malte,Gress Thomas M.,Beckers Marie-Claire,Maréchal Daniel,Bauer Andrea,Schröder Christoph,Hoheisel Jörg D.

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference85 articles.

1. Pancreatic carcinoma;Warshaw;N Engl J Med,1992

2. American gastroenterological association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma;Gastroenterology,1999

3. Early detection of pancreatic carcinoma;Rosty;Hematol Oncol Clin North Am,2002

4. Early detection and biomarkers in pancreatic cancer;Misek;J Natl Compr Canc Netw,2007

5. Advances in the treatment of pancreatic cancer: limitations of surgery and evaluation of new therapeutic strategies;Yokoyama;Surg Today,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rutin Inhibits Hepatic and Pancreatic Cancer Cell Proliferation by Inhibiting CYP3A4 and GST;Indian Journal of Pharmaceutical Education and Research;2023-06-05

2. DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy;Frontiers in Oncology;2022-12-08

3. TRPC1 channels regulate the activation of pancreatic stellate cells through ERK1/2 and SMAD2 pathways and perpetuate their pressure-mediated activation;Cell Calcium;2022-09

4. Cancer Proteomics: New Horizons and Insights into Therapeutic Applications;Current Proteomics;2021-08-10

5. Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation;OncoTargets and Therapy;2021-06